Friday 6 November 2026 Export ACAD’s income statement to Excel — free account

ACADIA Pharmaceuticals Inc.

ACADIA Pharmaceuticals Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.1 billion, up 11.9% from fiscal 2024.

Revenue: +22.9%
EPS: −27.9%
Free cash flow: +141.2%

Quarter to September 2026, against a year earlier

Revenue growth 10 yrs

21.23 0.01 −0.05%

Follow ACAD

Alert me

Market cap: $3.7B
P/E: 10.0×
Fwd P/E: 33.4×
Dividend yield: —
F-score: 6/9
Altman Z: 7.90
Beneish M: −0.89
Dividend safety: n/a

Overview

	Older periods	Dec '25	Mar '26	Jun '26	Sep '26
P/E ratio Full definition →	+8 more quarters Free account	11.51	9.98	11.24	9.46
P/S ratio Full definition →		4.20	3.47	3.81	2.89
P/FCF ratio Full definition →		0.00	0.00	0.00	0.00
P/Operating CF Full definition →		(92.28)	111.70	43.08	302.25
P/B ratio Full definition →		3.66	3.04	3.32	2.51
Price to Tangible BV Full definition →		4.02	3.32	3.61	2.78
EV/Sales Full definition →		3.43	2.69	2.97	2.08
EV/EBITDA Full definition →		33.08	33.10	35.22	18.70
EV/Operating CF Full definition →		33.48	23.84	21.12	25.64
EV/FCF Full definition →		(39.55)	(35.02)	(65.04)	(21.61)
Quick Ratio Full definition →		3.49	3.27	3.11	3.48
Current Ratio Full definition →		3.83	3.59	3.39	3.82
Net Debt/EBITDA Full definition →		(41.72)	410.14	(23.36)	(12.98)
Debt/Assets Full definition →		0.00%	0.00%	0.00%	0.00%
Debt/Equity Full definition →		0.00	0.00	0.00	0.00
Asset Turnover Full definition →		0.78	0.80	0.77	0.77
Operating CF/Net income Full definition →		(0.18)	9.34	3.20	0.21
Capex/Depreciation Full definition →		(1.78)	(2.05)	(1.64)	(0.35)
Research and Development Expense of Revenue Full definition →		29.85%	28.68%	26.48%	22.29%
Selling, General and Administrative Expense of Revenue Full definition →		54.80%	63.80%	52.04%	46.51%
Intangible Assets out of Total Assets Full definition →		0.07	0.07	0.06	0.08
Share Based Compensation of Revenue Full definition →		4.66%	5.48%	5.50%	5.10%
Graham Net Nets Full definition →		0.16	0.19	0.18	0.25
Graham Number Full definition →		19.51	19.16	19.63	19.63
Earnings Yield Full definition →		8.69%	10.02%	8.89%	10.57%
Free Cash Flow Yield Full definition →		(2.07%)	(2.22%)	(1.20%)	(3.33%)
Revenue per Share Full definition →		1.69	1.57	1.79	1.98
Operating CF per Share Full definition →		(0.29)	0.20	0.59	0.07
Capex per Share Full definition →		(0.02)	(0.03)	(0.03)	(0.01)
Free Cash Flow per Share Full definition →		(0.31)	0.17	0.56	0.06
Cash per Share Full definition →		4.87	4.99	5.57	5.66
Shareholders Equity per Share Full definition →		7.29	7.32	7.61	8.04
Interest Debt per Share Full definition →		0.00	0.00	0.00	0.00
Book value per Share Full definition →		7.29	7.32	7.61	8.04
Free Cash Flow Full definition →		(52.74)	28.77	95.69	10.26
Working Capital Full definition →		785.00	790.49	863.11	936.21
Capital Expenditures Full definition →		(4.00)	(5.21)	(5.09)	(1.24)
Net Current Asset Value Full definition →		725.31	738.85	788.25	861.76
EV/EBIT Full definition →		35.08	36.39	39.20	20.44
Capex to Sales Full definition →		0.01	0.02	0.02	0.00
Price to Operating Income Full definition →		42.90	46.92	50.27	28.42
Other line items
Average Receivables Full definition →		126.46	131.05	143.01	158.88
Average Payables Full definition →		13.55	15.17	32.33	19.04
Average Inventory Full definition →		28.31	27.26	29.25	34.73
Average Assets Full definition →		1,375.98	1,368.80	1,484.23	1,562.46
Average Common Equity Full definition →		980.09	1,006.65	1,064.50	1,152.38

Show all line items

Columns are period end dates · fundamentals updated 6 Nov 2026

Stockrow Weekly